CS logo
small CS logo
Metropolis Dermatology

Los Angeles, California, United States
Dermatologist in Los Angeles, California
888 S Figueroa St Suite 1050, Los Angeles, CA 90017

About Metropolis Dermatology


"Board-certified dermatologist Dr. James Y. Wang, received his training from Harvard Medical School, UCLA Medical Center, and Memorial Sloan Kettering Cancer Center. He founded Metropolis Dermatology in DTLA to be a full-service comprehensive skincare center offering medical dermatology appointments for general skin health and for treatment of skin cancers, acne, psoriasis, and rashes. In addition, cosmetic consultations for injectables, radiofrequency microneedling, PRP, bodysculpting/fat loss treatments, and a variety of laser technologies are also available. We hope you visit our beautiful clinic and join our dermatology family in the vibrant downtown LA community."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Metropolis Dermatology


During the past decade, Metropolis Dermatology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Metropolis Dermatology" #1 collaborator was "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Metropolis Dermatology


According to Clinical.Site data, the most researched conditions in "Metropolis Dermatology" are "Atopic Dermatitis" (1 trials) and "Papulopustular Rosacea" (1 trials). Many other conditions were trialed in "Metropolis Dermatology" in a lesser frequency.

Clinical Trials Intervention Types at Metropolis Dermatology


Most popular intervention types in "Metropolis Dermatology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (1 trials), "Rifaximin" (1 trials), "Ruxolitinib" (1 trials) and "Vehicle Cream" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Metropolis Dermatology


The vast majority of trials in "Metropolis Dermatology" are 2 trials for "All" genders.

Clinical Trials Status at Metropolis Dermatology


Currently, there are NaN active trials in "Metropolis Dermatology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Metropolis Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Metropolis Dermatology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".